Korea S.E.
18:00:00 2024-05-30 EDT
5-day change
1st Jan Change
1,452
KRW
-2.75%
+1.26%
+47.71%
Medifron DBT Co., Ltd. announced that it has received KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm
On September 15, 2021, Medifron DBT Co., Ltd. closed the transaction.
Hyper Corporation Inc. completed the acquisition of unknown minority stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. and AdQUA Interactive Inc.
05-29
CI
AdQUA Interactive Inc. completed the acquisition of 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd..
05-29
CI
Medifron DBT Co., Ltd. completed the acquisition of 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd..
05-29
CI
Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd.
04-25
CI
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..
04-04
CI
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion.
04-04
CI
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion.
04-04
CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.
03-27
CI
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion
02-15
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding
02-14
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 20.999999826 billion in funding from FSN Co., Ltd.
02-14
CI
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd
22-12-13
CI
Medifron DBT Co., Ltd.(KOSDAQ:A065650) dropped from S&P Global BMI Index
22-09-19
CI
Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding
22-08-23
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 3 billion in funding
22-08-21
CI
Medifron DBT Co., Ltd. announced that it has received KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.
22-06-29
CI
Medifron DBT to Raise $3.9 Million via Stock Offering
22-06-22
MT
Medifron DBT to Raise $10 Million via Stock Offering
22-06-22
MT
Medifron DBT Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.
22-06-21
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 12.9999915 billion in funding from Best Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. and other investors
22-06-21
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4.9999995 billion in funding from T Scientific Co.,Ltd
22-06-21
CI
Medifron DBT Co., Ltd. announced that it has received KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm
21-09-14
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm
21-09-12
CI
Medifron DBT Co., Ltd. announced that it has received KRW 14.99999874 billion in funding from T Scientific Co., Ltd.
21-02-04
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 14.99999874 billion in funding from T Scientific Co., Ltd.
20-12-29
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Hyper Corporation Inc, formerly Medifron DBT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of information and communication devices. The Company operates through three segments. The Information and Communication Technology Business segment is engaged in the manufacture and sale of gaming mice, gaming monitors, televisions, routers, and gaming devices. The Home Meal Replacement segment is engaged in the manufacture and supply of convenient meals. The New Drug Business segment is engaged in the development and sales of Alzheimer's treatments, non-narcotic painkillers, and early diagnosis kits for dementia.
More about the company
1st Jan change
Capi.
+47.71% 88.16M +82.43% 99.15B +21.30% 35.72B +3.95% 22.94B +9.22% 19.58B +2.75% 17.8B +12.09% 15.18B +4.80% 11.72B +21.59% 11.17B +13.59% 9.89B
Other Computer Hardware
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
HYPER CORPORATION INC. 
